NEWSROOM
IN THE KNOW BLOG
NEWS RELEASES
FEATURED NEWS
MEDIA INQUIRIES
MEDIA INQUIRIES
For general media inquiries, please use the Media Inquiries Form. Please note that this form is only available to members of the media.
For all others, use the General Contact Form.
IN THE KNOW BLOG
Stay updated on the latest legislative, regulatory and general information updates about the CBD and cannabinoid industries.
CBDA Insider’s Update: Week of April 27, 2020
A lot is going on here in the US and internationally – and the CBD Association has got you covered! Here are some recent developments: Will CBD Help in the Fight Against COVID-19? Israel Research Team Seeks Answer According to Benzinga, last week, InnoCan Pharma announced a collaboration with Tel Aviv University to instill CBD medicine through exosomes — or the small cell structures created when...
CBDA Insider’s Update: Week of April 20, 2020
A lot is going on here in the US and internationally – and the CBD Association has got you covered! Here are some recent developments: 1. In Canada, Thousands of Acres of Greenhouse Space Sits Empty – Can They Pivot to Assist in Canada’s Food Shortage? Thousands of square feet of shuttered cannabis greenhouses are now lying empty in British Columbia and Ontario due to the sudden and...
Seek a Second Opinion – Regulatory Void Is Creating A Lot of Bad Advice
In this time of quarantine, I spend a lot of my day like many of you – searching the internet. As an attorney in the cannabis and CBD industry, I’m especially interested in the latest news and updates on all things CBD. As many of you know, much like the information available about COVID-19, there is a lot of misleading and sometimes flat-out wrong information available about cannabis and...
CBD Insider’s Update: Week of April 12, 2020
A lot is going on here in the US and internationally – and the CBD Association has got you covered! Here are some recent developments: DEA Deschedules Epidiolex – First Cannabis Drug in 21st Century The only FDA approved product containing CBD – Epidiolex – was in Schedule V of the Controlled Substances Act. As of April 12, 2020, Epidiolex is completely descheduled as a controlled substance by...
CBD Insider’s Update: Week of March 16, 2020
A lot is going on here in the US and internationally – and the CBD Association has got you covered! Here is what happened just in the past few weeks: USDA Secretary calls interim hemp rules a ‘draft.’ Hemp farmers and stakeholders welcomed a late February announcement when the USDA (for now) lifted enforcement action requiring that hemp be tested in U.S. Drug Enforcement...
Key Issues Everyone Must Consider When Reading FDA’s CBD Report To Congress
Executive Summary: On March 5, FDA issued a 15-page report to Congress concerning CBD. Below, the CBD Association explores five issues raised by that report and invites feedback. Those issues are: 1. Can FDA and the Administration define an acceptable regulatory pathway for use of CBD in non-drug products that would not impede its further development as a pharmaceutical? As the FDA considers...
Federal and State Insider’s Update: Week of March 9, 2020
At the CBD Association, we hear from two broad classes of stakeholders interested in legislative developments involving cannabinoids, especially CBD. The first are businesses which today have ‘skin in the game’. These include growers, processors, contract manufacturers, brand owners, retailers, and allied industries. The second group includes (a) companies which may have quietly commissioned...
Why Do We Need Yet Another Cannabis Trade Association?
The million-dollar question we keep getting asked by organizations representing the CBD and cannabis industries is “why do we need yet another CBD and cannabis association”. Here’s our billion-dollar answer. Shortly after the passage of the 2018 Farm Bill, members of our team were approached by individuals and companies hungry to jump into the cannabis industry, seeking advice about how to...
Comments To The USDA Concerning The Interim Final Rule for The U.S. Domestic Hemp Program
On behalf of the CBD Association and its member companies, we are submitting comments concerning the Interim Final Rule for the U.S. Domestic Hemp Program (the “IFR”).1 The CBD Association (CBDA) is the only 501(c)(6) non-profit trade association established in Washington, D.C. that exclusively and holistically promotes CBD and cannabis-derived products worldwide. CBDA engages policymakers at...
OUR TEAM
MORE ABOUT US +
ADVOCACY
MORE 〉
EDUCATION
FIND OUT MORE +
BECOME A MEMBER
JOIN TODAY +
UPCOMING EVENTS
FIND EVENTS +
VERIFICATION
FIND OUT MORE +
BUSINESS SERVICES
MORE INFO +
COMMUNCATIONS
MORE ABOUT US 〉